Delivery Order SPE2DB22D2009-SPE2DB24FL5YY

Award Date 10/18/23
Potential Completion Date 10/19/23
Potential Value $443
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $1,274.60 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the supply of 4561828673 Novolog 100 unit/ml Flexpen 3ml insulin delivery devices. As the prime contractor, Amerisourcebergen Drug Corp will deliver the requested medical supplies to the place of performance in Conshohocken, Pennsylvania within the period of performance from August 16 to August 17, 2023. The Defense Logistics Agency utilizes...
This delivery order for $2,283.98 was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp on October 18, 2023 for the delivery of 4562523512 Novolog 100 unit/ml Flexpen 3ml insulin pens. The place of performance is Conshohocken, Pennsylvania and all items are to be delivered by October 19, 2023 under firm fixed pricing. No set-aside designation was applied to this order, which was issued against an existing prime vendor contract vehicle to support the Defense Logistics...
<p>This delivery order for $306 was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, located in Conshohocken, Pennsylvania, for the delivery of 100 unit/ml Flexpen insulin pens. The order calls for the delivery of three boxes of Novolog insulin by October 23, 2023 under a firm fixed price contract structure. No subcontractors or set-aside designations were associated with this delivery order for medical supplies to support Defense Logistics Agency programs.</p>
This delivery order for $34 of Novolog 100 unit/ml FlexPen 3ml insulin awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp will be performed in Conshohocken, Pennsylvania. The order was awarded on October 19, 2023 under an existing contract vehicle and has a completion date of October 20, 2023. As the Defense Logistics Agency is responsible for worldwide logistics support of the Department of Defense, this order is likely supporting medical treatment for service members. No...
Defense Logistics Agency awarded a $340 firm fixed price delivery order to Amerisourcebergen Drug Corp for the purchase of Novolog 100 unit/ml FlexPen 3ml insulin injection devices. The delivery order was issued under an existing contract vehicle on September 26, 2023, with performance at the awardee's location in Conshohocken, Pennsylvania and a completion date of September 27, 2023. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical...
The Defense Logistics Agency awarded a delivery order valued at approximately $627 to Amerisourcebergen Drug Corporation for the supply of Novolog 100 unit/ml FlexPen 3ml insulin delivery devices. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning August 18-21, 2023. No set aside designation or subcontractors were indicated. The Defense Logistics Agency supports all branches of the U.S. military by procuring,...
The Defense Logistics Agency awarded a $136,160 delivery order to Amerisourcebergen Drug Corporation for the purchase of 4562187610 Novolog 100 unit/ml Flexpen 3ml insulin delivery devices. The firm fixed price order is being fulfilled from the contractor's facility located in Conshohocken, Pennsylvania, with performance taking place from September 15-18, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for diabetes medication will...
The Defense Logistics Agency awarded a $3,823.80 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for the supply of 4562343873 Novolog 100 unit/ml Flexpen 3ml insulin delivery devices. As the parent company of Amerisourcebergen Drug Corp, Amerisourcebergen Corporation will perform the contract through its Amerisourcebergen Corporation Division operating as Amerisourcebergen. Place of performance will be Amerisourcebergen's facility located in Conshohocken,...
The Defense Logistics Agency awarded a $2,403.57 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561503017 Novolog 100 unit/ml FlexPen 3ml insulin injectors to be delivered to a facility in Conshohocken, Pennsylvania between July 14-17, 2023. As a major supplier of medical materiel to the Department of Defense, this order for Novolog insulin delivery devices supports the Agency's mission to provide critical supplies and equipment to military treatment facilities...
The Defense Logistics Agency awarded a $2,393.68 firm fixed price delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 4562249845 Novolog 100 unit/ml Flexpen 3ml insulin injectors. The delivery order was issued under an indefinite-delivery/indefinite-quantity contract vehicle and has a period of performance from September 20th through September 21st, 2023. Amerisourcebergen will fulfill the order from its facility located in Conshohocken, Pennsylvania and provide the...
  • SPE2DB22D2009
    Indefinite Delivery Contract
  • SPE2DB22D2009-SPE2DB24FL5YY
    Delivery Order

This delivery order for $442 was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp for the delivery of 4562523294 Novolog 100 unit/ml Flexpen 3ml insulin devices. The order has a firm fixed price and place of performance in Conshohocken, Pennsylvania, with completion by October 19, 2023. No set-aside designation was used for this small order in support of the Defense Logistics Agency's medical supply chain responsibilities. Amerisourcebergen will deliver the contracted insulin devices from its corporate headquarters location.

Generated 1/17/24, 10:28 AM